Functional Diagnostic Accuracy of Quantitative Flow Ratio in Tandem Lesions and Virtual Stenting

NCT ID: NCT03405506

Last Updated: 2025-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

308 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-13

Study Completion Date

2017-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. Virtual stent implantation technique combined with QFR was recently developed to predict the functional significance of coronary stenosis as if the stenosis was revascularized.

The purpose of this study is to evaluate the diagnostic accuracy of QFR in in tandem lesions with fractional flow reserve (FFR) as the reference standard. The secondary purpose is to evaluate the diagnostic accuracy of QFR-based virtual stent technique in predicting the FFR values after revascularizing the culprit lesion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

QFR is a novel method for evaluating the functional significance of coronary stenosis by calculation of the pressure drop in the vessel. 3D coronary models can be reconstructed based on two angiographic projections to obtain the geometric parameters, including vascular diameter or cross-sectional area. According to the lesion stenosis, vessel curvature, conical geometry and reference lumen characteristics, pressure drop can be calculated in real time based on its relationship with blood flow. There is no need for pressure wire and adenosine / ATP induced maximum hyperemia compared with FFR.

The FAVOR Pilot Study and FAVOR II China Study showed promising results for diagnostic accuracy in consecutive patients. However, the diagnostic accuracy of QFR in specific tandem lesions needs further investigation. Furthermore, using the virtual stent technology to accurately assess the culprit lesion and choose the optimal treatment is significant in precisely guiding PCI surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Cardiovascular Diseases Myocardial Ischemia Arterial Occlusive Diseases Heart Diseases Vascular Diseases Arteriosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quantitative Flow Ratio (QFR)

FFR measured by pressure wire, QFR computed by coronary angiographic images

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Stable and unstable angina pectoris or secondary evaluation of stenosis after acute MI;
2. Age \> 18 years;
3. Able to provide signed informed consent.

1. At least two localized lesions on the same coronary artery;
2. More than 50% diameter stenosis (DS) estimated by QCA on each lesion;
3. At least 10 mm relatively normal lumen (at most 20% DS) between two lesions;
4. Reference vessel size \> 2 mm in stenotic segment by visual estimate.

Exclusion Criteria

1. Ineligible for diagnostic intervention or FFR examination;
2. Myocardial infarction within 72 hours;
3. Severe heart failure (NYHA≥III);
4. S-creatinine\>150µmol/L or GFR\<45 ml/kg/1.73m2;
5. Allergy to contrast agent or adenosine;
6. Factors that might substantially impact the angiographic image quality, e.g, frequent atrial premature beat or atrial fibrillation;
7. Serious complications:

1. Evidence of cardiac rupture;
2. History of bleeding (intracranial hemorrhage, gastrointestinal bleeding, etc.);
3. Acute or chronic blood system diseases, including hemoglobin \< 10 g / L, or platelet count \< 50 × 109 / L;
4. Accompanied by other diseases might inducing life expectancy shorter than several months;
5. History of severe renal insufficiency and hypohepatia (liver failure, cirrhosis, portal hypertension and active hepatitis)
6. Aneurysm, arterial / venous malformation, aortic dissection;
8. Cardiogenic shock or circulation capacity failure;
9. Two-degree and more severe atrioventricular block, with no permanent pacemaker implanted;
10. Pregnancy or lactation;
11. The investigators believe that the treatment regimen may be detrimental to the patient or the enrollment of this subject may affect the specific assessment of the trial;

1. The interrogated stenosis is caused by myocardial bridge;
2. Ostial lesions less than 3 mm to the aorta;
3. Side branches of the bifurcation lesions with Median Classification of 111 or 101;
4. Severe overlap or shorten of stenosis segment;
5. Severe tortuosity of target vessel;
6. Poor angiographic image quality precluding contour detection.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Chest Hospital

OTHER

Sponsor Role collaborator

Pulse Medical Imaging Technology (Shanghai) Co., Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Huadong Hospital affiliated to Fudan University

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Tu S, Westra J, Yang J, von Birgelen C, Ferrara A, Pellicano M, Nef H, Tebaldi M, Murasato Y, Lansky A, Barbato E, van der Heijden LC, Reiber JHC, Holm NR, Wijns W; FAVOR Pilot Trial Study Group. Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035. doi: 10.1016/j.jcin.2016.07.013.

Reference Type BACKGROUND
PMID: 27712739 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CARDIAC201701

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CT-FFR-guided Strategy for In-stent Restenosis
NCT05611190 NOT_YET_RECRUITING NA